Advancements in Presbyopia Treatment: Laser Scleral Microporation

Presbyopia — the gradual loss of the eye’s ability to focus on nearby objects — is a natural part of aging that affects almost everyone over the age of 40. Traditionally, patients have managed presbyopia with reading glasses, multifocal contact lenses, or lens replacement surgeries. However, 2025 brings exciting developments that could shift the way clinicians and patients approach this common condition.

At the upcoming ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting, Ace Vision Group is set to present the latest advancements in laser scleral microporation — a minimally invasive, non-lens-based procedure aimed at restoring the eye’s dynamic range of focus.

What is Laser Scleral Microporation?

Laser scleral microporation involves using a specialised laser to create a precise grid of micropores in the sclera, the white outer layer of the eye. These micropores are strategically placed to enhance the biomechanical flexibility of the eye, improving its ability to adjust focus dynamically — a capability that diminishes with age and leads to presbyopia.

Unlike procedures that focus on reshaping the cornea or replacing the natural lens with artificial intraocular lenses (IOLs), scleral microporation works by modifying the structural properties of the eye itself, aiming to restore its youthful accommodative abilities.

Why Is This Development Significant?

The traditional treatment options for presbyopia, while effective, often involve trade-offs:

• Reading glasses can be inconvenient and stigmatising.
• Multifocal contact lenses and multifocal IOLs can cause issues with contrast sensitivity or halos.
• Surgical lens replacements are invasive and permanent.

Laser scleral microporation offers a minimally invasive alternative with several potential advantages:

• Preservation of the natural lens and natural vision dynamics
• No removal or replacement of tissue
• Reversible or adjustable outcomes, depending on future developments
• Minimal downtime and a less invasive recovery process compared to traditional surgery

For patients seeking to maintain a more natural visual experience, without relying on glasses or committing to permanent lens replacement, this technique could become a compelling option.

Current Evidence and Future Outlook

Initial studies on scleral microporation, including earlier pilot trials, have shown promising results in improving near and intermediate vision without significant impact on distance vision. Moreover, the procedure’s safety profile appears favorable, with minimal complications reported thus far.

The presentation by Ace Vision Group at ASCRS 2025 is highly anticipated because it will reveal new clinical trial data and refinements to the laser delivery system, potentially positioning scleral microporation as a frontline therapy for early presbyopia management.

If larger-scale studies continue to confirm its efficacy and safety, we could see a major shift in how eye care professionals counsel presbyopic patients, moving from “compensation” with glasses and lenses toward true restoration of visual function.

As the global population ages and demands more sophisticated solutions for age-related conditions, innovations like laser scleral microporation are not just exciting — they are essential.
The ability to address presbyopia with a minimally invasive, biomechanical approach offers new hope for millions seeking to retain their visual independence and quality of life.

The ophthalmology and optometry community will be watching the developments from ASCRS 2025 closely, and patients will no doubt be eager to hear when this new treatment might become widely available.